Your Article Summary
See Latest ArticlesClinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout
Journal of Rheumatology, 06/11/09
Becker MA et al. – Data show that durable maintenance of goal range serum urate (SUA) level with either dose of febuxostat or in smaller numbers of subjects with allopurinol resulted in near elimination of gout flares and improved tophus status over time.
Methods- Aim was to determine longterm urate-lowering efficacy and clinical benefits and safety of therapy with febuxostat or allopurinol in subjects with gout
- Subjects (n=1086) were assigned to fixed-dose daily urate-lowering treatment (ULT) with febuxostat (80 mg or 120 mg) or allopurinol (300 mg)
- ULT reassignment was permitted during mo 1 to 6 to achieve SUA concns between 3.0 and <6.0 mg/dl
- Flares requiring treatment, tophus size, safety, and SUA levels were monitored during up to 40 mo of ULT maintenance
- After 1 mo initial treatment, >80% of subjects receiving either febuxostat dose, but only 46% of subjects receiving allopurinol, achieved SUA <6.0 mg/dl
- After ULT reassignment, >80% of all remaining subjects maintained the primary efficacy endpoint of SUA <6.0 mg/dl at each visit
- More subjects initially randomized to allopurinol required ULT reassignment to achieve SUA <6.0 mg/dl vs subjects receiving febuxostat
- Maintenance of SUA <6.0 mg/dl resulted in progressive reduction to nearly 0 in proportion of subjects requiring gout flare treatment
- Baseline tophus resolution was achieved by 46%, 36%, and 29% of subjects maintained on febuxostat 80 mg, febuxostat 120 mg, and allopurinol, respectively
- Overall adverse event rates adjusted for 10-fold greater febuxostat than allopurinol exposure, did not differ among treatment groups
Related Articles
Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia
Cancer, 10/26/09
Relevance Score: 66%
Anthropometric and Skeletal Phenotype in Men with Idiopathic Osteoporosis and Their Sons Is Consistent with Deficient Estrogen Action during Maturation
Journal of Clinical Endocrinology and Metabolism, 10/12/09
Relevance Score: 46%
Relationship Between Prostate-specific Antigen and Hematocrit: Does Hemodilution Lead to Lower PSA Concentrations in Men With a Higher Body Mass Index
Urology, 10/28/09
Relevance Score: 45%
Blood pressure lowering efficacy of alpha blockers for primary hypertension
Cochrane Reviews, 10/09/09
Relevance Score: 45%
A Comparative MRI Study of Upper and Lower Lumbar Motion Segments in Patients With Low Back Pain
Journal of Spinal Disorders & Techniques, 10/05/09
Relevance Score: 45%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
Journal of Dermatological Treatment , 12/04/09
Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis
Journal of Rheumatology, 12/04/09
Role and place of methotrexate in vasculitis management
International Journal of Clinical Rheumatology, 12/04/09
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09
The modern management of gout
Rheumatology, 10/08/09
Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 11/02/09